Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.
about
Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumorsElectrochemotherapy: from the drawing board into medical practiceDifferential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vesselsA numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissuePhysical non-viral gene delivery methods for tissue engineeringElectrochemotherapy: a new technological approach in treatment of metastases in the liverSegmentation of hepatic vessels from MRI images for planning of electroporation-based treatments in the liver.Basal cell carcinoma: 10-year experience with electrochemotherapy.Histopathological findings in colorectal liver metastases after electrochemotherapy.Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.Electrochemotherapy for treatment of skin and soft tissue tumours. Update and definition of its role in multimodal therapy.Selective cytotoxicity of intense nanosecond-duration electric pulses in mammalian cells.Differential cellular effects of electroporation and electrochemotherapy in monolayers of human microvascular endothelial cells.Hemorrhage control of liver injury by short electrical pulsesDynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks"Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.Modeling of microvascular permeability changes after electroporationIn vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice.Cutaneous metastasis of unknown primary presenting as massive and invasive abdominal lesion: an elective approach with electrochemotherapyAntitumor efficiency of electrochemotherapy by high and low frequencies and repetitive therapy in the treatment of invasive ductal carcinoma in BALB/c miceThe effect of blood flow on magnetic resonance imaging of non thermal irreversible electroporation.Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.Electrodes for in vivo localised subcutaneous electropulsation and associated drug and nucleic acid delivery.Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy.Treatment of metastatic melanoma with electrochemotherapy.Irreversible electroporation of the liver: is there a safe limit to the ablation volume?3D nanochannel electroporation for high-throughput cell transfection with high uniformity and dosage control.Pulse timing during irreversible electroporation achieves enhanced destruction in a hindlimb model of cancer.In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment.Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation.Low electric field parameters required to induce death of cancer cells.Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study.Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.Radiofrequency currents exert cytotoxic effects in NB69 human neuroblastoma cells but not in peripheral blood mononuclear cellsElectrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study.Tumor size and effectiveness of electrochemotherapy.Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion.Efficacy of suicide gene therapy in hypoxic rat 9L glioma cells.
P2860
Q26822537-36A38DF9-4D6A-4F3C-A02D-A4C74EF4A673Q26863455-0E8FBB8B-A623-4E69-8D20-B9C4A0E2418FQ27333617-DBB1B30A-F3BB-42EE-B1A9-B29AE36C9D56Q28541799-70083D01-4FD3-4CF5-BE8F-4E549D2A9FB5Q30370201-97560B4E-281D-42BA-8ADF-A1CED99A1536Q30557077-A39F5CB4-93DB-4F3B-ABD0-2415BE9DE2E5Q30563308-4153A1CA-0B74-4458-BB88-ED40E4FA8EA0Q33750383-922EBAD2-4B86-4EC5-92CB-D6C1FCC240EEQ33884224-FBD39D94-C4A0-4D68-A1BF-DB72A84CA87DQ34022431-3313064C-9614-475C-93EA-D2AE47A5ADEEQ34025351-7E43B58F-AA7E-45FE-8832-C642DFA2945CQ34107635-3A5CE275-841A-4AA9-8596-02E4C29595A9Q34541063-FE1399CC-1F6B-4597-A315-DF268030CC19Q34548134-33F02388-AF88-4274-A2FB-2519DD7709E1Q35077659-BDBB7D9B-ABC3-4CE5-B4EB-F283D7A1966CQ35086705-F0723861-57CB-4E57-8873-FF75CA38C435Q35185012-AA9E0E41-935B-492A-B12F-24A2CA5F545CQ35203487-49BB0BB8-B743-4780-81DD-7A9C058C08D1Q36297880-9EB03BE9-7D1E-4172-A92A-05757C90AD90Q36398303-58B22027-372E-454E-9144-DA330CE7BF17Q36645081-8669C2BF-0AE9-4D73-86FA-1F4CEA5E7AA8Q37266919-F7C2C203-F753-4436-892E-92F4EFAE2837Q37580062-42EE1F8B-B7DE-4A90-B7B0-1F5D30D44450Q37622247-8CCAE189-36FD-414B-BD80-BF1B02B1E9B7Q38078075-26FF2856-38C1-406B-9033-673B15414ED0Q38081808-3D3E7954-C375-4A9E-946A-0BB15B4B57C1Q38200101-7F3ABABD-A9F9-4E44-9920-0344F021800AQ38782132-2A73EFD7-7692-4E05-8BBB-4EEAB425B681Q38840635-BC4998C5-6A0E-4F2B-AD5D-2F0E2D63D809Q38951902-B746DA5B-8A86-42F9-903D-703AF4645332Q39069431-CF2E6322-E3DC-41E3-A39D-FB4A3B0E004DQ39109750-9F5CBD26-16EB-4313-B51B-42502D483F16Q39144552-CE712471-3872-40A1-939E-7AB5C727A85FQ39172952-B1B71240-EDCF-420F-93C9-D787B529A869Q39245878-D67FB9C2-1ED6-423E-87AD-3630BEC6F23EQ39306583-2ECF278E-89CD-4C12-9650-2A460759923FQ39324450-F90F2079-0450-4F52-A1C1-9674C15464C1Q39459398-5CCB68DF-DCED-46CD-9004-CA8FF62D3FDCQ39807501-A6D794BD-A83E-48FA-97C8-EEE737592E86Q39966239-DAF79415-BEBA-4CEC-B243-A3C16198B3A0
P2860
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Vascular disrupting action of ...... th bleomycin in murine sarcoma
@nl
Vascular disrupting action of ...... h bleomycin in murine sarcoma.
@ast
Vascular disrupting action of ...... h bleomycin in murine sarcoma.
@en
type
label
Vascular disrupting action of ...... th bleomycin in murine sarcoma
@nl
Vascular disrupting action of ...... h bleomycin in murine sarcoma.
@ast
Vascular disrupting action of ...... h bleomycin in murine sarcoma.
@en
prefLabel
Vascular disrupting action of ...... th bleomycin in murine sarcoma
@nl
Vascular disrupting action of ...... h bleomycin in murine sarcoma.
@ast
Vascular disrupting action of ...... h bleomycin in murine sarcoma.
@en
P2093
P2860
P3181
P356
P1476
Vascular disrupting action of ...... th bleomycin in murine sarcoma
@en
P2093
M Podkrajsek
M Sentjurc
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6604168
P407
P577
2008-01-08T00:00:00Z
P5875
P6179
1029086058